Сальвин

Quick links to important sections

Сальвин

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Сальвин

Property Description
Active Ingredient Salviae Officinalis Foliorum Extract (Common sage leaf extract)
Form Tablet (lozenge) or Liquid Extract (tincture)
Pharmacological Class Herbal Medicinal Product / Phytogenic agent
General Purpose Local antiseptic and anti-inflammatory support
Origin Natural (Derived from Salvia officinalis plant)

Defining Сальвин: Classification as a Herbal Medicinal Product

Сальвин is defined as a phytogenic drug, meaning it is a medicine derived exclusively from natural plant sources, and is classified as a Herbal Medicinal Product (HMP). Its core identity is tied to the active ingredient, Salviae Officinalis Foliorum Extract, which is a standardized extract obtained from the leaves of the common sage plant (Salvia officinalis). Unlike synthetic chemical drugs, Сальвин operates through the complex, synergistic activity of multiple compounds naturally present in the extract, a characteristic profile of plant-based pharmacotherapy. Sage leaf extract has a well-established use for its properties, distinguishing it from purely synthetic agents. The medicine is characterized by a long history of safe and traditional application.

Composition and Available Forms of Sage Leaf Extract

The active substance, Salviae Officinalis Foliorum Extract, is a complex reservoir of natural compounds, primarily containing essential oil components (such as cineol and borneol), various tannins, and polyphenols (like rosmarinic acid). The essential oils extracted from Salvia officinalis possess recognized antimicrobial actions, supporting the drug’s general role in local defense. Сальвин is typically presented in forms suitable for local administration, most commonly as a solid tablet (lozenge) or as a concentrated liquid extract (tincture). The dual availability of dosage forms, particularly the lozenge, facilitates direct, controlled release of the antiseptic and anti-inflammatory components in the mouth and throat.

General Purpose: Antiseptic and Anti-inflammatory Action

The overall function of Сальвин centers on providing a localized antiseptic and anti-inflammatory action to superficial tissues. The essential oil fractions within the extract exert a mild antimicrobial activity, helping to defend against the proliferation of surface microorganisms, while the tannins and polyphenols contribute to tissue soothing. The efficacy of sage extract for addressing local inflammation, such as minor irritation in the mouth and throat, is recognized for its potential to help calm discomfort. This combination of actions positions the medicine for general support in maintaining the hygienic integrity and comfort of membranes, making it a well-established non-prescription option for minor localized issues.

What side effects are possible with Сальвин?

Possible side effects and safety information

Adverse Reaction Scope

The medicine's regulatory safety profile is largely characterized by a low incidence of adverse effects at typical doses. The primary type of reaction documented in official sources concerns Immune system disorders, specifically hypersensitivity (allergic reactions), which are classified as Rare.

Category Classification Description
Frequency Rare Hypersensitivity reactions (Allergic Reactions)
Frequency Not Known Gastrointestinal symptoms (e.g., nausea, vomiting)
SOC Immune System Disorders Associated with allergic reactions
SOC Nervous System Disorders Associated with high-dose risk only

Serious Adverse Reactions and Dose-Related Risk

Official regulatory documents note a significant dose-dependent safety concern related to the essential oil component thujone, which is naturally present in the extract. High-level intake of the essential oil has been reported to cause severe reactions, classified as Serious Adverse Reactions, including epileptiform convulsions (seizures), tachycardia, and vertigo. This risk is explicitly tied to excessive doses, with official limits set on the maximum daily exposure to thujone to mitigate potential neurotoxicity.

Population-Specific Safety Considerations

Specific use is not recommended in certain populations due to a lack of sufficient regulatory data to establish safety:

  • Pregnancy and Lactation: Use is not recommended.
  • Children and Adolescents (under 18 years): Use is not recommended.

Safety-Related Restrictions

Hypersensitivity to the active substance(s) is an official contraindication. Furthermore, regulatory texts impose an official restriction on the maximum daily thujone exposure (below 6.0 mg per person) to control the potential for systemic toxicity.

Regulatory Safety Summary

  • Documented adverse reactions are infrequent, primarily involving immune system responses.
  • The most significant safety constraint is the dose-dependent risk of neurotoxicity/seizures from the thujone component at excessive doses.
  • Official labeling recommends against use in pediatric, pregnant, and lactating populations due to insufficient safety data.

This framework outlines the official safety boundaries for the product's use, focusing strictly on label-derived adverse effects and limitations.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Profile: Salvinorin A

Authoritative sources indicate that the main active compound associated with substances referred to as "Сальвин" (Salvinorin A) typically produces intense, but very short-lived, psychedelic-like changes when inhaled, lasting generally under 30 minutes. To date, there have been no documented fatalities directly attributed to an overdose of Salvinorin A alone.

Overdose presentations are generally characterized by extreme, transient psychological effects, including intense visual hallucinations, strong dissociative states, and feelings of lost identity or confusion, which often resolve quickly.

When to Seek Immediate Medical Attention

Despite the short duration of effects, any instance of suspected overdose is a medical emergency that requires immediate professional evaluation. Call emergency services immediately if the person displays any signs of a severe reaction or overdose, which may be due to co-ingestion with other substances or underlying health conditions.

Signs that require urgent medical attention include:

  • Unconsciousness or inability to be awakened.
  • Difficulty breathing, very slow or shallow breathing, or gurgling/choking sounds.
  • Seizures or convulsions.
  • Severe disorientation, agitation, or loss of control that poses a risk of trauma or injury.

Therapeutic Uses of Сальвин

What Сальвин treats: main uses and benefits

Сальвин, derived from sage leaf extract, is commonly used for the symptomatic relief of minor inflammatory conditions affecting the oral cavity and pharynx. The therapeutic use of sage leaf includes the relief of certain distressing symptoms associated with inflammations in the mouth or throat.

The medication is applicable in settings that involve acute or disruptive symptom patterns, and is used to help address symptom clusters like scratchiness, dryness, and the burning sensation often accompanying the onset of mild pharyngitis. It is also commonly used across conditions characterized by periods of heightened symptoms, such as mild cases of gingivitis (gum tenderness), stomatitis (irritation of the oral mucosa), and non-severe, localized lesions like aphthous ulcers.

“The primary goal of using this herbal preparation is to provide support that helps ease the overall symptom burden during periods of localized discomfort.”

This support helps patients cope more steadily with difficult episodes by contributing to improved comfort. It is applied in scenarios where additional management of discomfort is required, assisting with the symptomatic relief of irritative and inflammatory states.


Quick Fact: Relief for Localized Irritation Сальвин is relevant for managing symptoms that interfere with daily comfort when associated with minor, non-systemic inflammation confined to the superficial tissues of the mouth and throat.

Eligibility and Restrictions for Use

Сальвин (Salvin), which is an extract derived from the leaves of Sage (Salvia officinalis), is generally used as a topical agent for treating inflammatory conditions of the oral cavity, throat, and larynx. Its properties include anti-edematous and astringent effects.

Who Can Use Сальвин?

Patient Group Indication
Adults Inflammatory diseases of the mouth, pharynx, or larynx (e.g., stomatitis, gingivitis, pharyngitis, tonsillitis).
Children Use is often determined by the specific formulation and is generally not recommended for very young children due to lack of extensive safety data. Always consult a healthcare professional.

Contraindications (Who Should Not Use Сальвин)

Сальвин is not suitable for everyone. Patients should avoid using this preparation if they have a known hypersensitivity or allergic reaction to Salvia officinalis (Sage) or any other components of the specific drug formulation.

Due to the presence of ethanol in some extract formulations, specific warnings or contraindications may apply, such as in patients with certain medical conditions or those taking interacting medications. As with many herbal or extract-based medicines, caution is usually advised during pregnancy and breastfeeding unless specifically directed by a physician. Always review the product's full patient information leaflet and consult a healthcare provider before use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns for Сальвин (Salviae Officinalis Foliorum Extract) as defined in government regulatory labeling for this herbal medicinal product.

Pharmacodynamic Interaction with CNS Depressants

  • Medicinal product categories with documented interactions: Medicinal products acting via the GABA receptor (Central Nervous System depressants).
  • Specific interacting medicines (explicitly listed): Barbiturates and Benzodiazepines are cited in regulatory documentation as examples of GABA-acting products.
  • Interaction-related restrictions: Due to the potential for an additive sedative effect, the regulatory document states that the concomitant use is not recommended with medicines that act on the GABA receptor.

Pharmacokinetic and Other Interactions

  • Mechanistic basis of interactions: No specific pharmacokinetic interaction (e.g., CYP enzyme inhibition or transporter modulation) is formally reported in the interaction sections of the official European Union herbal monograph for the leaf extract, which focuses on well-established traditional use.
  • Timing-based interaction rules: No mandatory separation windows or specific timing requirements for administration are documented in the official regulatory product information.

Formulation-Related Substance Restriction

  • Interactions with other substances: Liquid formulations, such as the tincture, may contain ethanol (alcohol) as a solvent. Regulatory constraints require the product information to include appropriate labeling detailing the alcohol content for products that contain it.

Mechanism of Action

How Сальвин Works

Сальвин (Salvinorin A) operates primarily by engaging the body's opioid system, but with a specialized action that focuses on modulating specific signaling pathways. The mechanistic domains outlined below describe the drug's core action at the biological and physiological level.


Selective Kappa-Opioid Receptor Agonism

This domain covers the drug's foundational action: its role as a selective full agonist at the kappa-opioid receptor (KOR), a G-protein coupled receptor. Engaging the KOR initiates an inhibitory G-protein cascade (Gi/o) that decreases neuronal excitability and the release of various neurotransmitters. This primary action influences neural signaling pathways involved in perception and mood.


Indirect Modulation of Central Dopaminergic Pathways

This mechanism describes how KOR activation leads to a reduction in overall dopaminergic activity, particularly in key areas of the reward and motivation circuitry like the striatum. By suppressing the release of dopamine, Сальвин engages mechanisms that decrease the activity of reward-related signaling. This effect on the motivation system contributes to the drug's changes in perception and sensory processing.

Dosage and Administration Information

Administration Guidelines

The use of Сальвин, which contains Salviae Officinalis Folium Extract, is intended for oromucosal administration, meaning the preparation is applied locally to the mouth and throat. The primary routes of intake are via rinsing, gargling, or direct local application, depending on the specific dosage form. The medicine is available as a liquid extract (tincture) and in solid preparations such as lozenges, with the administration procedure defined by the formulation.

When using the liquid extract for gargling or rinsing, the product is required to be diluted in water prior to use. This diluted preparation is typically administered several times daily, often three times per day, to achieve local delivery of the active compounds. Conversely, local application of an undiluted tincture or gel may be performed up to five times daily.

The continuous use of this preparation is short-term, with a maximum continuous treatment course limited to one week. If the need for administration persists beyond this duration, medical consultation is required. Constraints on use exist across populations, and administration is not recommended for children and adolescents under 18 years of age due to a lack of sufficient data defining the usage profile in this group. The overall daily amount must also be kept within defined limits for total thujone exposure.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Сальвин

Research on Сальвин (Salvinorin A) is currently at a preclinical and early basic science stage. This means most of the knowledge about its potential effects comes from laboratory studies using animal models, with only limited human research exploring its acute effects on the brain in highly controlled settings. There are currently no approved clinical uses for the compound.


Evidence for Potential Use in Pain Management

The vast majority of research in this area was conducted using controlled animal experiments. Studies examined how Сальвин affected outcomes related to physical discomfort, with findings describing patterns observed in animal models, including measurements of increased pain thresholds. Research examined effects related to inflammatory or irritative states in observed animal populations. The translatability of these findings to human effectiveness is not established, and certainty remains low. Data on pain management in human clinical trials are currently insufficient.

Evidence for Potential Use in Substance Use Disorders

Research explored this compound's effect on behaviors related to drug seeking and reward using controlled animal experiments designed to approximate substance dependence. Studies monitored changes in specific drug-seeking behaviors in animal models. This research contributes to the broader evidence landscape related to behavioral responses. However, findings were mixed and varied depending on the specific research model used. It is not fully established if the patterns observed in animal models are predictive of clinical outcomes in human substance use disorders.

Evidence from Basic Psychopharmacology and Brain Studies

Small, basic science studies were conducted in healthy human volunteers using brain imaging (fMRI) and questionnaires to measure outcomes related to systemic or functional imbalance. Studies reported patterns of transient shifts in brain activity and connectivity following administration, and participants experienced temporary alterations in their patient-reported outcomes describing perceived discomfort. These findings are considered low certainty as they are exploratory and do not reflect effects in clinical populations. Sample sizes were modest.


Key Limitations and Areas of Research Uncertainty

Across all areas of investigation, the evidence is limited and preliminary. Most findings are derived from animal studies, which only provide context and do not determine whether an individual will respond similarly. Human research is characterized by modest sample sizes and limited follow-up durations, contributing to a low level of certainty regarding any potential therapeutic use. No formal research has been published to evaluate the effects or safety patterns of Сальвин in children, older adults, pregnant populations, or individuals with multiple comorbid conditions.

Key Studies & References

  1. Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders
  2. Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain

Frequently Asked Questions (FAQ)

Common questions about Сальвин (FAQ)

Q: How quickly do most people notice an effect after starting Сальвин?

A: Studies examining the use of sage extract for throat discomfort suggest that symptomatic relief may be observed within the first two hours following administration. Responses to the product may differ between individuals. Official product information is generally focused on the overall benefit over the course of use, rather than a specific immediate onset time.

Q: What are the most commonly reported side effects of Сальвин?

A: According to official regulatory documents, the most frequently reported adverse effects of the product are classified as Rare, such as hypersensitivity (allergic reactions). For many other potential reactions, the frequency is often stated as Not Known, indicating that while they may occur, their commonality has not been definitively established in official data.

Q: Is it normal to feel slightly dizzy or lightheaded when first taking Сальвин?

A: Official warnings note that dizziness, or vertigo, is a Serious Adverse Reaction associated with taking excessive doses of the active extract due to the component thujone. The regulatory documents do not typically list dizziness as a common side effect at the normal, approved dosage. If unexpected effects occur, official guidance generally advises patients to consult a healthcare provider.

Q: Does consuming alcohol affect the safety or effectiveness of Сальвин?

A: Liquid forms of Сальвин often contain ethanol (alcohol) as an ingredient, and this content must be specified on the product label. Furthermore, because the extract may have an additive effect with Central Nervous System (CNS) depressants, the official information may advise against its use with other substances, including alcohol, that also cause sedation or drowsiness.

Q: Can taking Сальвин cause stomach upset or digestive issues?

A: Regulatory documents list gastrointestinal symptoms, such as nausea or vomiting, as potential adverse reactions associated with the product. However, the official frequency of these effects is classified as Not Known. Persistent digestive discomfort is generally managed with the guidance of a healthcare provider.

Q: Does Сальвин cause long-term side effects that I should be aware of?

A: The continuous use of Сальвин is officially restricted to short-term use, typically no longer than one week, due to regulatory constraints regarding the safety of the thujone component. Because of this short duration of use, regulatory documents do not establish a safety or side-effect profile for long-term continuous administration.

Q: Is it possible for Сальвин to affect my heart rate or blood pressure?

A: Official safety warnings indicate that taking excessive doses of the essential oil component can lead to serious adverse reactions, including tachycardia (a rapid heart rate). Effects on heart rate or blood pressure at standard therapeutic doses are not generally documented as a common occurrence in official product information.

Q: How long does the effect of one dose of Сальвин typically last?

A: The administration instructions for Сальвин typically direct that the product be applied several times daily, often three times per day, to maintain a controlled local effect. This repeated application indicates that the intended beneficial effect of a single local dose is transient.

Q: Does Сальвин interact with common pain relievers like ibuprofen or paracetamol?

A: The official interaction section primarily focuses on drugs that act on the Central Nervous System. However, some regulatory data suggest that sage extracts have been studied for their potential to affect certain liver enzymes (like Cytochrome P450 enzymes) that are responsible for breaking down many common medications, including some pain relievers. This potential suggests that caution should be exercised regarding concomitant use.

Q: Are there different strengths or forms of Сальвин, and how are they used?

A: Сальвин is most commonly available in forms suitable for local application, such as solid tablets (lozenges) or a concentrated liquid extract (tincture). The official administration procedure, such as gargling with a diluted solution or sucking a lozenge, is defined by the specific physical form of the product.

Q: Is it safe to drive or operate machinery while taking Сальвин?

A: Due to the potential for interactions with Central Nervous System depressants, which could cause an additive sedative effect, official product information often includes warnings regarding the potential for impaired mental ability or drowsiness. Individuals using the product should be mindful of its potential impact on their ability to drive or operate machinery safely.

Q: Does Сальвин affect cholesterol or other fat levels in the blood?

A: Exploratory scientific studies have examined the effects of sage leaf extracts on blood fat levels, such as cholesterol and triglycerides, in certain research populations. These findings are considered exploratory research and do not constitute an established or approved therapeutic claim for the product.

Q: Does Сальвин interfere with the effectiveness of contraceptives (birth control)?

A: Official interaction data is primarily focused on pharmacodynamic effects. However, some regulatory bodies have noted that components within sage may possess properties similar to estrogen. This information suggests that use alongside hormonal contraceptives may require consideration.

Q: What is the risk if Сальвин is taken with herbal supplements like St. John's Wort?

A: The official documentation does not typically list specific herbal interactions. However, since the extract may affect certain liver enzymes, this indicates why a cautious approach to using multiple medications or supplements is necessary.

Q: Can I use Сальвин if I have a history of glaucoma or similar eye conditions?

A: Official labeling may require warnings for products that could interact with medications that block the effects of acetylcholine (anticholinergic drugs), which are sometimes used to manage eye conditions. The potential for interaction means that use should be considered in the context of any pre-existing eye conditions or related medications.

Q: How do the benefits of Сальвин outweigh the risks, according to official documents?

A: Regulatory assessment reports generally conclude that the benefits of the product for its approved, traditional use (for inflammatory conditions of the mouth and throat) outweigh the known risks. This conclusion is explicitly conditioned on the product being used strictly according to the officially recommended dosage and the short duration of use defined in the product information.

How should Сальвин be stored and disposed of?

How to Store and Dispose of Сальвин (Salvin)

The official storage conditions for the 1% alcohol solution of Сальвин are strictly defined to protect the medicine's stability, which relies on the integrity of the natural sage extract.

Mandatory Storage Conditions

The regulatory label requires specific environmental controls:

  • Temperature: Store at a temperature not higher than 20 C.
  • Light Protection: The medicine must be stored in a place protected from light and kept in its original dark glass packaging.
  • Child Safety: Сальвин must be kept out of the reach of children.

Stability and Handling

Solutions prepared immediately before use (such as 0.1%-0.25% dilutions) must be used fresh as they have a significantly limited stability period. No explicit instructions for household disposal of unused or expired product are provided in the regulatory documents.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Сальвин found in:

A-Z Index: